These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 2429441)
1. Role of glycoproteins of pseudorabies virus in eliciting neutralizing antibodies. Ben-Porat T; DeMarchi JM; Lomniczi B; Kaplan AS Virology; 1986 Oct; 154(2):325-34. PubMed ID: 2429441 [TBL] [Abstract][Full Text] [Related]
2. Pseudorabies virus glycoprotein gI: in vitro and in vivo analysis of immunorelevant epitopes. Fuchs W; Rziha HJ; Lukàcs N; Braunschweiger I; Visser N; Lütticken D; Schreurs CS; Thiel HJ; Mettenleiter TC J Gen Virol; 1990 May; 71 ( Pt 5)():1141-51. PubMed ID: 1693164 [TBL] [Abstract][Full Text] [Related]
3. Glycoprotein B of Aujeszky's disease virus: topographical epitope mapping and epitope-specific antibody response. Zaripov MM; Morenkov OS; Siklodi B; Barna-Vetro I; Gyöngyösi-Horvath A; Fodor I Res Virol; 1998; 149(1):29-41. PubMed ID: 9561562 [TBL] [Abstract][Full Text] [Related]
4. Identification of the pseudorabies virus glycoprotein gp50 as a major target of neutralizing antibodies. Eloit M; Fargeaud D; L'Haridon R; Toma B Arch Virol; 1988; 99(1-2):45-56. PubMed ID: 2833202 [TBL] [Abstract][Full Text] [Related]
5. Pseudorabies virus glycoprotein gIII is a major target antigen for murine and swine virus-specific cytotoxic T lymphocytes. Zuckermann FA; Zsak L; Mettenleiter TC; Ben-Porat T J Virol; 1990 Feb; 64(2):802-12. PubMed ID: 2153244 [TBL] [Abstract][Full Text] [Related]
6. Mapping and characterization of neutralizing epitopes of glycoproteins gIII and gp50 of the Indiana-Funkhauser strain of pseudorabies virus. Coe NE; Mengeling WL Arch Virol; 1990; 110(1-2):137-42. PubMed ID: 1689995 [TBL] [Abstract][Full Text] [Related]
7. Correlation between gI, gII, gIII, and gp 50 antibodies and virus excretion in vaccinated pigs infected with pseudorabies virus. Eloit M; Vannier P; Hutet E; Fournier A Arch Virol; 1992; 123(1-2):135-43. PubMed ID: 1312820 [TBL] [Abstract][Full Text] [Related]
8. Blocking ELISA to distinguish pseudorabies virus-infected pigs from those vaccinated with a glycoprotein gIII deletion mutant. Kit S; Awaya Y; Otsuka H; Kit M J Vet Diagn Invest; 1990 Jan; 2(1):14-23. PubMed ID: 1965296 [TBL] [Abstract][Full Text] [Related]
9. Time course of the porcine cellular and humoral immune responses in vivo against pseudorabies virus after inoculation and challenge: significance of in vitro antigenic restimulation. De Bruin MG; De Visser YE; Kimman TG; Bianchi AT Vet Immunol Immunopathol; 1998 Sep; 65(1):75-87. PubMed ID: 9802578 [TBL] [Abstract][Full Text] [Related]
10. Protection from pseudorabies virus challenge in mice by a combination of purified gII, gIII and gVI antigens. Matsuda Tsuchida A; Katayama S; Okada N; Okabe T; Sasaki N J Vet Med Sci; 1992 Jun; 54(3):447-52. PubMed ID: 1322712 [TBL] [Abstract][Full Text] [Related]
11. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. van Zijl M; Wensvoort G; de Kluyver E; Hulst M; van der Gulden H; Gielkens A; Berns A; Moormann R J Virol; 1991 May; 65(5):2761-5. PubMed ID: 1850051 [TBL] [Abstract][Full Text] [Related]
12. Characterization and mapping of a nonessential pseudorabies virus glycoprotein. Wathen MW; Wathen LM J Virol; 1986 Apr; 58(1):173-8. PubMed ID: 3005646 [TBL] [Abstract][Full Text] [Related]
13. Development of a competitive double antibody lateral flow assay for the detection of antibodies specific to glycoprotein B of Aujeszky's disease virus in swine sera. Vrublevskaya VV; Afanasyev VN; Grinevich AA; Skarga YY; Gladyshev PP; Ibragimova SA; Krylsky DV; Morenkov OS J Virol Methods; 2017 Feb; 240():54-62. PubMed ID: 27894861 [TBL] [Abstract][Full Text] [Related]
14. A study comparing the immunologic responses of swine to pseudorabies viral antigens based on the ELISA, serum virus neutralization, and latex agglutination tests. Schoenbaum MA; Beran GW; Murphy DP J Vet Diagn Invest; 1990 Jan; 2(1):29-34. PubMed ID: 1965298 [TBL] [Abstract][Full Text] [Related]
15. Two classes of protective antibodies against Pseudorabies virus variant glycoprotein B: Implications for vaccine design. Li X; Yang F; Hu X; Tan F; Qi J; Peng R; Wang M; Chai Y; Hao L; Deng J; Bai C; Wang J; Song H; Tan S; Lu G; Gao GF; Shi Y; Tian K PLoS Pathog; 2017 Dec; 13(12):e1006777. PubMed ID: 29261802 [TBL] [Abstract][Full Text] [Related]
16. The detection of antibodies to the glycoprotein X antigen of pseudorabies virus. Cook D; Hill H; Snyder M; McMahon P; Kinker D J Vet Diagn Invest; 1990 Jan; 2(1):24-8. PubMed ID: 1965297 [TBL] [Abstract][Full Text] [Related]
17. A comparison of differential diagnostic tests to detect antibodies to pseudorabies glycoproteins gX, gI, and gIII in naturally infected feral pigs. Schmitt BJ; Osorio FA; Stroup WW; Gibbs EP J Vet Diagn Invest; 1991 Oct; 3(4):344-5. PubMed ID: 1662082 [No Abstract] [Full Text] [Related]
18. Induction of protective immunity and neutralizing antibodies to pseudorabies virus by immunization of anti-idiotypic antibodies. Tsuda T; Onodera T; Sugimura T; Murakami Y Arch Virol; 1992; 124(3-4):291-300. PubMed ID: 1318708 [TBL] [Abstract][Full Text] [Related]
19. Antibody response to glycoprotein I in maternally immune pigs exposed to a mildly virulent strain of pseudorabies virus. van Oirschot JT; Daus F; Kimman TG; van Zaane D Am J Vet Res; 1991 Nov; 52(11):1788-93. PubMed ID: 1664670 [TBL] [Abstract][Full Text] [Related]
20. A highly specific and sensitive competitive enzyme-linked immunosorbent assay (ELISA) based on baculovirus expressed pseudorabies virus glycoprotein gE and gI complex. Gut M; Jacobs L; Tyborowska J; Szewczyk B; Bienkowska-Szewczyk K Vet Microbiol; 1999 Sep; 69(4):239-49. PubMed ID: 10535770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]